Trials / Completed
CompletedNCT01668108
A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer
Open, Multicenter Observational Study of Paclitaxel Utilized in Mono- or Combination Therapy for the Treatment of Breast Cancer, Non-small Cell Lung Cancer and Ovarial Cancer.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 770 (actual)
- Sponsor
- Onkovis GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main purpose of this observational study with Paclitaxel is to determine the number of treatment cycles and the quantity of Paclitaxel onkovis needed therefore under the special circumstance of ambulant chemotherapy. onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective. Secondary objectives are the survey of the side effects of Paclitaxel onkovis in comparison to Docetaxel. To this purpose, data regarding co medications and adverse events are also collected.
Conditions
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2012-08-17
- Last updated
- 2018-07-16
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01668108. Inclusion in this directory is not an endorsement.